Older News Items
20th-November-2019
NLRP3 inflammasome activation drives tau pathology in AD
4th-November-2019
Genetic Mutation May Hold Key to Alzheimers Treatment
29th-October-2019
Flotillin as a Diagnostic Blood Marker of Alzheimer’s Disease
15th-October-2019
Metabolic dysfunction as a cause of Alzheimers disease
7th-October-2019
Anticoagulant delays Alzheimers Disease pathogenesis in mouse model
2nd-October-2019
Inhibiting PI3Kδ to ameliorate AD pathology by reducing plaque accumulation and neuroinflammation
30th-September-2019
TOM-1 regulates neuroinflammatory response related to AD cognitive decline
10th-September-2019
10th-September-2019
Calcium channel blockers may be effective in treating memory loss
4th-September-2019
Involvement of calcineurin/NFATc4 pathway in a rat model of post-traumatic stress disorder
3rd-September-2019
Cognitive enhancement in AD patients from transcranial electromagnetic treatment
29th-August-2019
Impaired Mitochondrial Calcium Transport and AD
14th-August-2019
MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer’s disease risk
6th-August-2019
Discovery and replication of cerebral blood flow differences in major depressive disorder
15th-July-2019
Resveratrol-induced antidepressant- and anxiolytic-like effects are mediated by PDE4D